Effect of sample collection tubes on cerebrospinal fluid concentrations of tau proteins and amyloid β peptides

被引：128
作者：
Lewczuk, P
Beck, G
Esselmann, H
Bruckmoser, R
Zimmermann, R
Fiszer, M
Bibl, M
Maler, JM
Kornhuber, J
Wiltfang, J
机构：
[1] Univ Erlangen Nurnberg, Dept Psychiat & Psychotherapy, Mol Neurobiol Lab, D-91054 Erlangen, Germany
[2] Ctr Clin Neuroproteom, Erlangen, Germany
[3] Univ Gottingen, Dept Psychiat & Psychotherapy, D-3400 Gottingen, Germany
来源：
CLINICAL CHEMISTRY | 2006年 / 52卷 / 02期
关键词：
D O I：
10.1373/clinchem.2005.058776
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：332 / 334
页数：3
相关论文
共 11 条
[1]   Evaluation of CSF-tau and CSF-Aβ42 as diagnostic markers for Alzheimer disease in clinical practice [J].
Andreasen, N ;
Minthon, L ;
Davidsson, P ;
Vanmechelen, E ;
Vanderstichele, H ;
Winblad, B ;
Blennow, K .
ARCHIVES OF NEUROLOGY, 2001, 58 (03) :373-379
[2]   Cerebrospinal fluid amyloid β peptide patterns in Alzheimer's disease patients and nondemented controls depend on sample pretreatment:: Indication of carrier-mediated epitope masking of amyloid β peptides [J].
Bibl, M ;
Esselmann, H ;
Otto, M ;
Lewczuk, P ;
Cepek, L ;
Rüther, E ;
Kornhuber, J ;
Wiltfang, J .
ELECTROPHORESIS, 2004, 25 (17) :2912-2918
[3]   High cerebrospinal fluid tau and low amyloid β42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype [J].
Galasko, D ;
Chang, L ;
Motter, R ;
Clark, CM ;
Kaye, J ;
Knopman, D ;
Thomas, R ;
Kholodenko, D ;
Schenk, D ;
Lieberburg, I ;
Miller, B ;
Green, R ;
Basherad, R ;
Kertiles, L ;
Boss, MA ;
Seubert, P .
ARCHIVES OF NEUROLOGY, 1998, 55 (07) :937-945
[4]   Improved discrimination of AD patients using β-amyloid(1-42) and tau levels in CSF [J].
Hulstaert, F ;
Blennow, K ;
Ivanoiu, A ;
Schoonderwaldt, HC ;
Riemenschneider, M ;
De Deyn, PP ;
Bancher, C ;
Cras, P ;
Wiltfang, J ;
Mehta, PD ;
Iqbal, K ;
Pottel, H ;
Vanmechelen, E ;
Vanderstichele, H .
NEUROLOGY, 1999, 52 (08) :1555-1562
[5]   Neurochemical diagnosis of Alzheimer's dementia by CSF Aβ42, Aβ42/Aβ40 ratio and total tau [J].
Lewczuk, P ;
Esselmann, H ;
Otto, M ;
Maler, JM ;
Henkel, AW ;
Henkel, MK ;
Eikenberg, O ;
Antz, C ;
Krause, WR ;
Reulbach, U ;
Kornhuber, J ;
Wiltfang, J .
NEUROBIOLOGY OF AGING, 2004, 25 (03) :273-281
[6]   Tau protein phosphorylated at threonine 181 in CSF as a neurochemical biomarker in Alzheimer's disease - Original data and review of the literature [J].
Lewczuk, P ;
Esselmann, H ;
Bibl, M ;
Beck, G ;
Maler, JM ;
Otto, M ;
Kornhuber, J ;
Wiltfang, L .
JOURNAL OF MOLECULAR NEUROSCIENCE, 2004, 23 (1-2) :115-122
[7]   Effects of processing and storage conditions on amyloid β (1-42) and tau concentrations in cerebrospinal fluid:: Implications for use in clinical practice [J].
Schoonenboom, NSM ;
Mulder, C ;
Vanderstichele, H ;
Van Elk, EJ ;
Kok, A ;
Van Kamp, GJ ;
Scheltens, P ;
Blankenstein, MA .
CLINICAL CHEMISTRY, 2005, 51 (01) :189-195
[8]   Standardization of measurement of β-amyloid(1-42) in cerebrospinal fluid and plasma [J].
Vanderstichele, H ;
Van Kerschaver, E ;
Hesse, C ;
Davidsson, P ;
Buyse, MA ;
Andreasen, N ;
Minthon, L ;
Wallin, A ;
Blennow, K ;
Vanmechelen, E .
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2000, 7 (04) :245-258
[9]  
WILFANG J, 2002, J NEUROCHEM, V81, P481
[10]   Elevation of β-amyloid peptide 2-42 in sporadic and familial Alzheimer's disease and its generation in PS1 knockout cells [J].
Wiltfang, J ;
Esselmann, H ;
Cupers, P ;
Neumann, M ;
Kretzschmar, H ;
Beyermann, M ;
Schleuder, D ;
Jahn, H ;
Rüther, E ;
Kornhuber, J ;
Annaert, W ;
De Strooper, B ;
Saftig, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (46) :42645-42657
12